Cargando…
Hemofiltration or hemodialysis for acute kidney injury?
The optimal choice of modality for acute renal replacement therapy is unclear at present. Diffusive therapy (hemodialysis) removes small solutes mainly, whereas convective therapies (hemofiltration and hemodiafiltration) may also eliminate larger molecules such as myoglobin or cytokines. Conversely,...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580729/ https://www.ncbi.nlm.nih.gov/pubmed/22883968 http://dx.doi.org/10.1186/cc11450 |
_version_ | 1782260317656449024 |
---|---|
author | Jörres, Achim |
author_facet | Jörres, Achim |
author_sort | Jörres, Achim |
collection | PubMed |
description | The optimal choice of modality for acute renal replacement therapy is unclear at present. Diffusive therapy (hemodialysis) removes small solutes mainly, whereas convective therapies (hemofiltration and hemodiafiltration) may also eliminate larger molecules such as myoglobin or cytokines. Conversely, convective therapies might predispose patients to filter clotting and thus increased costs. A systematic review and meta-analysis of clinical trials could not find evidence for clinical benefits of either modality. Thus, the decision on renal replacement therapy modality still is based on the clinical status of the individual patient, the expertise of the medical and nursing staff, and local circumstances and availability. |
format | Online Article Text |
id | pubmed-3580729 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35807292013-08-10 Hemofiltration or hemodialysis for acute kidney injury? Jörres, Achim Crit Care Commentary The optimal choice of modality for acute renal replacement therapy is unclear at present. Diffusive therapy (hemodialysis) removes small solutes mainly, whereas convective therapies (hemofiltration and hemodiafiltration) may also eliminate larger molecules such as myoglobin or cytokines. Conversely, convective therapies might predispose patients to filter clotting and thus increased costs. A systematic review and meta-analysis of clinical trials could not find evidence for clinical benefits of either modality. Thus, the decision on renal replacement therapy modality still is based on the clinical status of the individual patient, the expertise of the medical and nursing staff, and local circumstances and availability. BioMed Central 2012 2012-08-10 /pmc/articles/PMC3580729/ /pubmed/22883968 http://dx.doi.org/10.1186/cc11450 Text en Copyright ©2012 BioMed Central Ltd |
spellingShingle | Commentary Jörres, Achim Hemofiltration or hemodialysis for acute kidney injury? |
title | Hemofiltration or hemodialysis for acute kidney injury? |
title_full | Hemofiltration or hemodialysis for acute kidney injury? |
title_fullStr | Hemofiltration or hemodialysis for acute kidney injury? |
title_full_unstemmed | Hemofiltration or hemodialysis for acute kidney injury? |
title_short | Hemofiltration or hemodialysis for acute kidney injury? |
title_sort | hemofiltration or hemodialysis for acute kidney injury? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580729/ https://www.ncbi.nlm.nih.gov/pubmed/22883968 http://dx.doi.org/10.1186/cc11450 |
work_keys_str_mv | AT jorresachim hemofiltrationorhemodialysisforacutekidneyinjury |